 | • レポートコード：MRC2-11QY12287 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は低カルシウム血症治療のグローバル市場について調査・分析したレポートです。種類別（無症候性、症候性、予防的）市場規模、用途別（病院、クリニック、研究）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別低カルシウム血症治療の競争状況、市場シェア ・世界の低カルシウム血症治療市場：種類別市場規模 2015年-2020年（無症候性、症候性、予防的） ・世界の低カルシウム血症治療市場：種類別市場規模予測 2021年-2026年（無症候性、症候性、予防的） ・世界の低カルシウム血症治療市場：用途別市場規模 2015年-2020年（病院、クリニック、研究） ・世界の低カルシウム血症治療市場：用途別市場規模予測 2021年-2026年（病院、クリニック、研究） ・北米の低カルシウム血症治療市場分析：米国、カナダ ・ヨーロッパの低カルシウム血症治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの低カルシウム血症治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の低カルシウム血症治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの低カルシウム血症治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：F. Hoffman La Roche、Novo Nordisk、Sanofi、GlaxoSmithKline (GSK)、Pfizer Inc.、Ranbaxy Pharmaceuticals Ltd. ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Hypocalcaemia is imbalance of electrolytes which is indicated by abnormally low level of calcium in the body. A healthy person has 8.5-10.2 mg/dL calcium level in his/her body, however, drop in this level could possibly led to hypocalcaemia disorder. Middle aged population needs to take 1000 mg of calcium while geriatrics population aged 65 and above should take 1500 mg of calcium per day. Hypocalcaemia is caused by hypoalbuminemia, hyperphosphatemia, surgical effects, medication effects, hypomagnesemia, heart failure, muscle cramps, vitamin D deficiency, alcoholism, magnesium deficiency, insufficient protein in the blood, in the blood and many more. Neuromuscular irritability is the most common sign of hypocalcaemia. Hypocalcaemia are mostly diagnosed by clinical suspicion and laboratory testing. Hypoparathyroidism has a major effect on hypocalcaemia and high recurrence rate.
Market Analysis and Insights: Global Hypocalcaemia Treatment Market
The global Hypocalcaemia Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Hypocalcaemia Treatment Scope and Market Size
Hypocalcaemia Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Hypocalcaemia Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
F. Hoffman La Roche
Novo Nordisk
Sanofi
GlaxoSmithKline (GSK)
Pfizer Inc.
Ranbaxy Pharmaceuticals Ltd.
…
Market segment by Type, the product can be split into
Asymptomatic
Symptomatic
Prophylactic
Market segment by Application, split into
Hosptial
Clinic
Research
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Hypocalcaemia Treatment Revenue
1.4 Market by Type
1.4.1 Global Hypocalcaemia Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Asymptomatic
1.4.3 Symptomatic
1.4.4 Prophylactic
1.5 Market by Application
1.5.1 Global Hypocalcaemia Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hosptial
1.5.3 Clinic
1.5.4 Research
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Hypocalcaemia Treatment Market Perspective (2015-2026)
2.2 Global Hypocalcaemia Treatment Growth Trends by Regions
2.2.1 Hypocalcaemia Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Hypocalcaemia Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Hypocalcaemia Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Hypocalcaemia Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Hypocalcaemia Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Hypocalcaemia Treatment Players by Market Size
3.1.1 Global Top Hypocalcaemia Treatment Players by Revenue (2015-2020)
3.1.2 Global Hypocalcaemia Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Hypocalcaemia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Hypocalcaemia Treatment Market Concentration Ratio
3.2.1 Global Hypocalcaemia Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Hypocalcaemia Treatment Revenue in 2019
3.3 Hypocalcaemia Treatment Key Players Head office and Area Served
3.4 Key Players Hypocalcaemia Treatment Product Solution and Service
3.5 Date of Enter into Hypocalcaemia Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Hypocalcaemia Treatment Historic Market Size by Type (2015-2020)
4.2 Global Hypocalcaemia Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Hypocalcaemia Treatment Market Size by Application (2015-2020)
5.2 Global Hypocalcaemia Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Hypocalcaemia Treatment Market Size (2015-2020)
6.2 Hypocalcaemia Treatment Key Players in North America (2019-2020)
6.3 North America Hypocalcaemia Treatment Market Size by Type (2015-2020)
6.4 North America Hypocalcaemia Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Hypocalcaemia Treatment Market Size (2015-2020)
7.2 Hypocalcaemia Treatment Key Players in Europe (2019-2020)
7.3 Europe Hypocalcaemia Treatment Market Size by Type (2015-2020)
7.4 Europe Hypocalcaemia Treatment Market Size by Application (2015-2020)
8 China
8.1 China Hypocalcaemia Treatment Market Size (2015-2020)
8.2 Hypocalcaemia Treatment Key Players in China (2019-2020)
8.3 China Hypocalcaemia Treatment Market Size by Type (2015-2020)
8.4 China Hypocalcaemia Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Hypocalcaemia Treatment Market Size (2015-2020)
9.2 Hypocalcaemia Treatment Key Players in Japan (2019-2020)
9.3 Japan Hypocalcaemia Treatment Market Size by Type (2015-2020)
9.4 Japan Hypocalcaemia Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Hypocalcaemia Treatment Market Size (2015-2020)
10.2 Hypocalcaemia Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Hypocalcaemia Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Hypocalcaemia Treatment Market Size by Application (2015-2020)
11 India
11.1 India Hypocalcaemia Treatment Market Size (2015-2020)
11.2 Hypocalcaemia Treatment Key Players in India (2019-2020)
11.3 India Hypocalcaemia Treatment Market Size by Type (2015-2020)
11.4 India Hypocalcaemia Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Hypocalcaemia Treatment Market Size (2015-2020)
12.2 Hypocalcaemia Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Hypocalcaemia Treatment Market Size by Type (2015-2020)
12.4 Central & South America Hypocalcaemia Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 F. Hoffman La Roche
13.1.1 F. Hoffman La Roche Company Details
13.1.2 F. Hoffman La Roche Business Overview
13.1.3 F. Hoffman La Roche Hypocalcaemia Treatment Introduction
13.1.4 F. Hoffman La Roche Revenue in Hypocalcaemia Treatment Business (2015-2020))
13.1.5 F. Hoffman La Roche Recent Development
13.2 Novo Nordisk
13.2.1 Novo Nordisk Company Details
13.2.2 Novo Nordisk Business Overview
13.2.3 Novo Nordisk Hypocalcaemia Treatment Introduction
13.2.4 Novo Nordisk Revenue in Hypocalcaemia Treatment Business (2015-2020)
13.2.5 Novo Nordisk Recent Development
13.3 Sanofi
13.3.1 Sanofi Company Details
13.3.2 Sanofi Business Overview
13.3.3 Sanofi Hypocalcaemia Treatment Introduction
13.3.4 Sanofi Revenue in Hypocalcaemia Treatment Business (2015-2020)
13.3.5 Sanofi Recent Development
13.4 GlaxoSmithKline (GSK)
13.4.1 GlaxoSmithKline (GSK) Company Details
13.4.2 GlaxoSmithKline (GSK) Business Overview
13.4.3 GlaxoSmithKline (GSK) Hypocalcaemia Treatment Introduction
13.4.4 GlaxoSmithKline (GSK) Revenue in Hypocalcaemia Treatment Business (2015-2020)
13.4.5 GlaxoSmithKline (GSK) Recent Development
13.5 Pfizer Inc.
13.5.1 Pfizer Inc. Company Details
13.5.2 Pfizer Inc. Business Overview
13.5.3 Pfizer Inc. Hypocalcaemia Treatment Introduction
13.5.4 Pfizer Inc. Revenue in Hypocalcaemia Treatment Business (2015-2020)
13.5.5 Pfizer Inc. Recent Development
13.6 Ranbaxy Pharmaceuticals Ltd.
13.6.1 Ranbaxy Pharmaceuticals Ltd. Company Details
13.6.2 Ranbaxy Pharmaceuticals Ltd. Business Overview
13.6.3 Ranbaxy Pharmaceuticals Ltd. Hypocalcaemia Treatment Introduction
13.6.4 Ranbaxy Pharmaceuticals Ltd. Revenue in Hypocalcaemia Treatment Business (2015-2020)
13.6.5 Ranbaxy Pharmaceuticals Ltd. Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Hypocalcaemia Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Hypocalcaemia Treatment Revenue
Table 3. Ranking of Global Top Hypocalcaemia Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Hypocalcaemia Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Asymptomatic
Table 6. Key Players of Symptomatic
Table 7. Key Players of Prophylactic
Table 8. Global Hypocalcaemia Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Hypocalcaemia Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Hypocalcaemia Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Hypocalcaemia Treatment Market Share by Regions (2015-2020)
Table 12. Global Hypocalcaemia Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Hypocalcaemia Treatment Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Hypocalcaemia Treatment Market Growth Strategy
Table 18. Main Points Interviewed from Key Hypocalcaemia Treatment Players
Table 19. Global Hypocalcaemia Treatment Revenue by Players (2015-2020) (Million US$)
Table 20. Global Hypocalcaemia Treatment Market Share by Players (2015-2020)
Table 21. Global Top Hypocalcaemia Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hypocalcaemia Treatment as of 2019)
Table 22. Global Hypocalcaemia Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Hypocalcaemia Treatment Product Solution and Service
Table 25. Date of Enter into Hypocalcaemia Treatment Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Hypocalcaemia Treatment Market Size by Type (2015-2020) (Million US$)
Table 28. Global Hypocalcaemia Treatment Market Size Share by Type (2015-2020)
Table 29. Global Hypocalcaemia Treatment Revenue Market Share by Type (2021-2026)
Table 30. Global Hypocalcaemia Treatment Market Size Share by Application (2015-2020)
Table 31. Global Hypocalcaemia Treatment Market Size by Application (2015-2020) (Million US$)
Table 32. Global Hypocalcaemia Treatment Market Size Share by Application (2021-2026)
Table 33. North America Key Players Hypocalcaemia Treatment Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Hypocalcaemia Treatment Market Share (2019-2020)
Table 35. North America Hypocalcaemia Treatment Market Size by Type (2015-2020) (Million US$)
Table 36. North America Hypocalcaemia Treatment Market Share by Type (2015-2020)
Table 37. North America Hypocalcaemia Treatment Market Size by Application (2015-2020) (Million US$)
Table 38. North America Hypocalcaemia Treatment Market Share by Application (2015-2020)
Table 39. Europe Key Players Hypocalcaemia Treatment Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Hypocalcaemia Treatment Market Share (2019-2020)
Table 41. Europe Hypocalcaemia Treatment Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Hypocalcaemia Treatment Market Share by Type (2015-2020)
Table 43. Europe Hypocalcaemia Treatment Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Hypocalcaemia Treatment Market Share by Application (2015-2020)
Table 45. China Key Players Hypocalcaemia Treatment Revenue (2019-2020) (Million US$)
Table 46. China Key Players Hypocalcaemia Treatment Market Share (2019-2020)
Table 47. China Hypocalcaemia Treatment Market Size by Type (2015-2020) (Million US$)
Table 48. China Hypocalcaemia Treatment Market Share by Type (2015-2020)
Table 49. China Hypocalcaemia Treatment Market Size by Application (2015-2020) (Million US$)
Table 50. China Hypocalcaemia Treatment Market Share by Application (2015-2020)
Table 51. Japan Key Players Hypocalcaemia Treatment Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Hypocalcaemia Treatment Market Share (2019-2020)
Table 53. Japan Hypocalcaemia Treatment Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Hypocalcaemia Treatment Market Share by Type (2015-2020)
Table 55. Japan Hypocalcaemia Treatment Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Hypocalcaemia Treatment Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Hypocalcaemia Treatment Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Hypocalcaemia Treatment Market Share (2019-2020)
Table 59. Southeast Asia Hypocalcaemia Treatment Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Hypocalcaemia Treatment Market Share by Type (2015-2020)
Table 61. Southeast Asia Hypocalcaemia Treatment Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Hypocalcaemia Treatment Market Share by Application (2015-2020)
Table 63. India Key Players Hypocalcaemia Treatment Revenue (2019-2020) (Million US$)
Table 64. India Key Players Hypocalcaemia Treatment Market Share (2019-2020)
Table 65. India Hypocalcaemia Treatment Market Size by Type (2015-2020) (Million US$)
Table 66. India Hypocalcaemia Treatment Market Share by Type (2015-2020)
Table 67. India Hypocalcaemia Treatment Market Size by Application (2015-2020) (Million US$)
Table 68. India Hypocalcaemia Treatment Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Hypocalcaemia Treatment Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Hypocalcaemia Treatment Market Share (2019-2020)
Table 71. Central & South America Hypocalcaemia Treatment Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Hypocalcaemia Treatment Market Share by Type (2015-2020)
Table 73. Central & South America Hypocalcaemia Treatment Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Hypocalcaemia Treatment Market Share by Application (2015-2020)
Table 75. F. Hoffman La Roche Company Details
Table 76. F. Hoffman La Roche Business Overview
Table 77. F. Hoffman La Roche Product
Table 78. F. Hoffman La Roche Revenue in Hypocalcaemia Treatment Business (2015-2020) (Million US$)
Table 79. F. Hoffman La Roche Recent Development
Table 80. Novo Nordisk Company Details
Table 81. Novo Nordisk Business Overview
Table 82. Novo Nordisk Product
Table 83. Novo Nordisk Revenue in Hypocalcaemia Treatment Business (2015-2020) (Million US$)
Table 84. Novo Nordisk Recent Development
Table 85. Sanofi Company Details
Table 86. Sanofi Business Overview
Table 87. Sanofi Product
Table 88. Sanofi Revenue in Hypocalcaemia Treatment Business (2015-2020) (Million US$)
Table 89. Sanofi Recent Development
Table 90. GlaxoSmithKline (GSK) Company Details
Table 91. GlaxoSmithKline (GSK) Business Overview
Table 92. GlaxoSmithKline (GSK) Product
Table 93. GlaxoSmithKline (GSK) Revenue in Hypocalcaemia Treatment Business (2015-2020) (Million US$)
Table 94. GlaxoSmithKline (GSK) Recent Development
Table 95. Pfizer Inc. Company Details
Table 96. Pfizer Inc. Business Overview
Table 97. Pfizer Inc. Product
Table 98. Pfizer Inc. Revenue in Hypocalcaemia Treatment Business (2015-2020) (Million US$)
Table 99. Pfizer Inc. Recent Development
Table 100. Ranbaxy Pharmaceuticals Ltd. Company Details
Table 101. Ranbaxy Pharmaceuticals Ltd. Business Overview
Table 102. Ranbaxy Pharmaceuticals Ltd. Product
Table 103. Ranbaxy Pharmaceuticals Ltd. Revenue in Hypocalcaemia Treatment Business (2015-2020) (Million US$)
Table 104. Ranbaxy Pharmaceuticals Ltd. Recent Development
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hypocalcaemia Treatment Market Share by Type: 2020 VS 2026
Figure 2. Asymptomatic Features
Figure 3. Symptomatic Features
Figure 4. Prophylactic Features
Figure 5. Global Hypocalcaemia Treatment Market Share by Application: 2020 VS 2026
Figure 6. Hosptial Case Studies
Figure 7. Clinic Case Studies
Figure 8. Research Case Studies
Figure 9. Hypocalcaemia Treatment Report Years Considered
Figure 10. Global Hypocalcaemia Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Hypocalcaemia Treatment Market Share by Regions: 2020 VS 2026
Figure 12. Global Hypocalcaemia Treatment Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Hypocalcaemia Treatment Market Share by Players in 2019
Figure 15. Global Top Hypocalcaemia Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hypocalcaemia Treatment as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Hypocalcaemia Treatment Revenue in 2019
Figure 17. North America Hypocalcaemia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Hypocalcaemia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Hypocalcaemia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Hypocalcaemia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Hypocalcaemia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Hypocalcaemia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Hypocalcaemia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
HER2陰性乳がん治療の世界市場（～2026年） HER2 (human epidermal growth factor receptor 2) is a protein that appears on the surface of some breast cancer cells. It may also be called HER2/neu or ErbB2.HER2-negative breast cancer means that the people have little or no HER2 protein. Market Analysis and Insights: Global HER2-negative breast ca…- 軟骨無形成症治療の世界市場（～2026年） Market Analysis and Insights: Global Achondroplasia Treatment Market The global Achondroplasia Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Achondroplasia Treatment Scope and Market Size Achondroplasia Tre…
- 逆流性腎症治療の世界市場（～2026年） Reflux nephropathy is kidney damage (nephropathy) due to urine flowing backward (reflux) from the bladder toward the kidneys. The symptoms of reflux nephropathy are comparable to nephrotic syndrome and infection of the urinary tract, though some individuals may not exhibit any evidence (symptom) of …
- 関節リウマチ治療の世界市場（～2026年） Rheumatoid arthritis is a long-term autoimmune disorder that primarily affects joints. The rheumatoid arthritis treatment market is expected to grow over the forecast period owing to the high incidence rate of rheumatoid arthritis among people. Market Analysis and Insights: Global Rheumatoid Arthrit…
- 酒さ治療の世界市場（～2026年） Rosacea is a chronic skin disease that generally affects the white population. Rising demand from European region is a major driver for the growth of the Rosacea Treatment market. Market Analysis and Insights: Global Rosacea Treatment Market The global Rosacea Treatment market size is projected to r…